157
Views
6
CrossRef citations to date
0
Altmetric
Review

Dual Bronchodilator in the Era of Triple Therapy

ORCID Icon, ORCID Icon, , , ORCID Icon, ORCID Icon, ORCID Icon, , , ORCID Icon & show all
Pages 2695-2705 | Published online: 28 Oct 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Kuo-Chen Cheng, Chih-Cheng Lai, Cheng-Yi Wang, Ching-Min Wang, Chung-Han Ho, Mei-I Sung, Shu-Chen Hsing, Kuang-Ming Liao & Shian-Chin Ko. (2022) The Impact of the Pay-for-Performance Program on the Outcome of COPD Patients in Taiwan After One Year. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 883-891.
Read now
Anastasia Papaporfyriou, Petros Bakakos, Georgios Hillas, Andriana I. Papaioannou & Stelios Loukides. (2022) Blood eosinophils in COPD: friend or foe?. Expert Review of Respiratory Medicine 16:1, pages 35-41.
Read now

Articles from other publishers (4)

Radhika R, Beena Thomas, Ahmed Rafad, Jerin James, Mekha Monsi Chenthiyethu & Ruben Thomas Lal. (2022) A study on the safety profile and clinical outcomes in patients using tulobuterol transdermal patch as an add on therapy in stable chronic obstructive pulmonary disease. IP Indian Journal of Immunology and Respiratory Medicine 7:1, pages 16-20.
Crossref
Raja Dhar, Deepak Talwar, Sundeep Salvi, B.V. Muralimohan, Sagar Panchal, Saiprasad Patil, Sagar Bhagat, Nishtha Khatri & Hanmant Barkate. (2022) Use of single-inhaler triple therapy in the management of obstructive airway disease: Indian medical experts’ review. ERJ Open Research 8:1, pages 00556-2021.
Crossref
A. I. Sinopalnikov. (2021) Pharmacotherapeutic strategy for COPD patients: focus on dual bronchodilators. Meditsinskiy sovet = Medical Council:16, pages 38-44.
Crossref
Sarah de Oliveira Rodrigues, Carolina Medina Coeli da Cunha, Giovanna Martins Valladão Soares, Pedro Leme Silva, Adriana Ribeiro Silva & Cassiano Felippe Gonçalves-de-Albuquerque. (2021) Mechanisms, Pathophysiology and Currently Proposed Treatments of Chronic Obstructive Pulmonary Disease. Pharmaceuticals 14:10, pages 979.
Crossref